Panadol Osteo price hike statement ambiguous but not misleading: ACCC

By Lucy Cormack
Updated October 28 2016 - 11:08am, first published October 10 2016 - 2:45pm
The entrance into the market of generic paracetamol 665mg products was found to have an impact on sales of Panadol Osteo. Photo: Adam Hollingworth
The entrance into the market of generic paracetamol 665mg products was found to have an impact on sales of Panadol Osteo. Photo: Adam Hollingworth
The ACCC found statements about Panadol Osteo pricing were unlikely to establish a contravention of the Australian Consumer Law.
The ACCC found statements about Panadol Osteo pricing were unlikely to establish a contravention of the Australian Consumer Law.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Cessnock news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.